A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease
Study sponsor: Prokidney
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-11-17Actual
Enrollment · participants10Actual
Source updated2025-03-24Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.